Ruping Dai | Cardiovascular Anesthesia | Best Researcher Award

Published on 25/02/202525/02/2025 by Cardiology and Cardiovascular Medicine

Prof. Dr. Ruping Dai | Cardiovascular Anesthesia | Best Researcher Award

Prof. Dr. Ruping Dai, Second Xiangya Hospital, China

Prof. Dr. Ruping Dai is the Director of Anesthesiology at the Second Xiangya Hospital, Central South University, China. He earned his Ph.D. in Clinical Medicine from the National University of Singapore in 2004 and completed postdoctoral research at the Institute of Molecular and Cell Biology, Singapore. Prof. Dai specializes in clinical anesthesia, pain management, intensive care, perioperative medicine, and organ protection. He has led four projects funded by the National Natural Science Foundation of China and has published 24 SCI papers. His accolades include the New Century Talent Support Program (2012) and the Hunan Province Outstanding Youth Fund (2013).

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Ruping Dai embarked on his academic journey at the Xiangya School of Medicine, Central South University, where he earned his Bachelor’s degree in Anesthesiology (1993-1998). His thirst for knowledge led him to pursue a Ph.D. in Medicine at the National University of Singapore (2000-2004), where he focused on advanced medical research. He further honed his expertise as a Postdoctoral Fellow at the National Institute of Molecular and Cell Biology, Singapore (2004-2006), gaining in-depth knowledge in molecular and cellular biology applications in anesthesiology.

🏥PROFESSIONAL ENDEAVORS:

Dr. Dai began his career in the Department of Cardiothoracic Surgery, Union Hospital Affiliated to Fujian Medical University (1998-2000), specializing in cardiovascular anesthesia and intensive care. Since October 2006, he has been a Chief Physician and Doctoral Supervisor at the Department of Anesthesiology, Second Xiangya Hospital, Central South University. Over the years, he has played a vital role in clinical anesthesia and Anesthesia Intensive Care Units (AICU), ensuring excellence in patient care and medical education.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR ANESTHESIA:

Dr. Dai’s research primarily focuses on anesthesiology, organ protection, perioperative care, and immunosuppression mechanisms in sepsis. He has led multiple groundbreaking studies on topics such as:

Postoperative sepsis mechanisms
Perioperative acute lung injury
Neuroplasticity and postoperative cognitive dysfunction (POCD)
Microglial/macrophage polarization in spinal cord ischemia-reperfusion injury

Dr. Dai has hosted 7 National Natural Science Foundation (NSFC) projects, receiving significant research funding, including:

Key Project on Hematogenous Macrophage Role in Postoperative Sepsis (2025-2028) – RMB 2.6 million
SIRT5-Mitochondrial Metabolic Axis in Perioperative Acute Lung Injury (2024-2027) – RMB 490,000
Macrophage Dysfunction in Sepsis Immunosuppression (2021-2024) – RMB 560,000
Microglia Polarization in Spinal Cord Ischemia-Reperfusion Injury (2018-2021) – RMB 540,000

🌍IMPACT AND INFLUENCE:

Dr. Dai holds several prestigious administrative positions, including:

Director of Anesthesiology, Second Xiangya Hospital, Central South University
Director, Institute of Anesthesiology, Central South University
Director, Hunan Anesthesia Clinical Medicine Research Center
Director, Hunan Provincial Organ Damage Prevention and Treatment Engineering Center

In academia, he serves as:

Deputy Chairman, Hunan Provincial Anesthesiology Committee
National Committee Member, Anesthesiology Branch, Chinese Medical Doctor Association
Vice Chairman, 13th Youth Committee of the Chinese Medical Association Anesthesiology Branch
Deputy Director, Orthopedics Group, Chinese Medical Association Anesthesiology Branch
Standing Committee Member, Cardiovascular Anesthesia Branch, Chinese Society of Thoracic and Cardiovascular Anesthesiology

📖ACADEMIC CITES AND SCHOLARLY CONTRIBUTIONS:

Dr. Dai has played a crucial role in education, having authored and co-edited several key textbooks:

Clinical Anesthesiology (First Editor, Science Press, 14th Five-Year Plan)
Postgraduate Textbook: Anesthesiology (Selected Topics of Basic Anesthesia Research, People’s Medical Publishing House, 2014)
Resident Medical Planning Textbook: Anesthesiology (Postoperative Acute Pain Management, People’s Medical Publishing House, 2014)
Co-translator of Miller’s Anesthesiology (7th & 8th editions, Opioids section, 2017)

🏆SCIENCE AND TECHNOLOGY AWARDS:

Dr. Dai’s excellence in research and innovation has earned him several prestigious awards, including:

Second Prize of Hunan Natural Science Award (2019)
Third “Light of Spirit” Excellent Youth Research Fund – Second Prize
Award-winning fund for Young and Middle-aged Excellent Paper Competition at the Chinese Anesthesia Annual Meeting

🔮LEGACY AND FUTURE CONTRIBUTIONS:

As a pioneering figure in anesthesiology, Dr. Dai continues to shape the future of perioperative medicine, critical care, and pain management. His leadership in cutting-edge research, education, and healthcare innovation ensures his lasting impact in the field. Through mentorship and research, he remains dedicated to improving patient outcomes and advancing medical science, setting a benchmark for future anesthesiologists worldwide.

🌟CONCLUSION:

Prof. Dr. Ru-Ping Dai is a distinguished anesthesiologist and researcher at the Second Xiangya Hospital, Central South University, China. As the Director of the Department of Anesthesiology, he has significantly advanced perioperative medicine, focusing on neuroimmune interactions and organ protection. His notable work includes elucidating the roles of brain-derived neurotrophic factor (BDNF) and its precursor, pro-BDNF, in mood disorders, offering new perspectives on neuroimmune crosstalk. Prof. Dai’s dedication to integrating clinical practice with research has enhanced patient care and contributed to the global medical community’s understanding of anesthesiology and neuroscience.

TOP NOTABLE PUBLICATIONS

Brain derived neurotrophic factor (BDNF) contributes to the pain hypersensitivity following surgical incision in the rats

Authors: CQ Li, JM Xu, D Liu, JY Zhang, RP Dai
Journal: Molecular Pain
Year: 2008

Local translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity

Authors: OK Melemedjian, DV Tillu, JK Moy, MN Asiedu, EK Mandell, S Ghosh, …
Journal: Molecular Pain
Year: 2014

Early-life social isolation-induced depressive-like behavior in rats results in microglial activation and neuronal histone methylation that are mitigated by minocycline

Authors: HT Wang, FL Huang, ZL Hu, WJ Zhang, XQ Qiao, YQ Huang, RP Dai, F Li, …
Journal: Neurotoxicity Research
Year: 2017

Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status

Authors: RP Dai, FX Yu, SR Goh, HW Chng, YL Tan, JL Fu, L Zheng, Y Luo
Journal: Journal of Biological Chemistry
Year: 2008

Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways

Authors: W Ruan, J Xu, S Li, L Yuan, R Dai
Journal: Cardiovascular Research
Year: 2012

Development of anxiety-like behavior via hippocampal IGF-2 signaling in the offspring of parental morphine exposure: effect of enriched environment

Authors: CQ Li, YW Luo, FF Bi, TT Cui, L Song, WY Cao, JY Zhang, F Li, JM Xu, …
Journal: Neuropsychopharmacology
Year: 2014

Dexmedetomidine reduces the incidence of fentanyl-induced cough: a double-blind, randomized, and placebo-controlled study

Authors: L He, JM Xu, RP Dai
Journal: Upsala Journal of Medical Sciences
Year: 2012

Adipocyte fatty acid-binding protein promotes palmitate-induced mitochondrial dysfunction and apoptosis in macrophages

Authors: H Li, Y Xiao, L Tang, F Zhong, G Huang, JM Xu, AM Xu, RP Dai, ZG Zhou
Journal: Frontiers in Immunology
Year: 2018

Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress

Authors: YW Luo, Y Xu, WY Cao, XL Zhong, J Duan, XQ Wang, ZL Hu, F Li, …
Journal: Neuropharmacology
Year: 2015

Biphasic activation of extracellular signal-regulated kinase in anterior cingulate cortex distinctly regulates the development of pain-related anxiety and mechanical …

Authors: RP Dai, CQ Li, JW Zhang, F Li, XD Shi, JY Zhang, XF Zhou
Journal: Anesthesiology
Year: 2011

Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Published on 25/02/202525/02/2025 by Cardiology and Cardiovascular Medicine

Prof. Dr. Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Prof. Dr. Zhuofeng Lin, Guangdong Medical University, China

Prof. Dr. Zhuofeng Lin is the Dean of the Experimental Animal Center and Dean of the Innovational Center of Cardiometabolic Disease at Guangdong Medical University, China. His research focuses on cross-organ communication in cardiovascular and metabolic diseases, particularly the role of metabolic hormones and obesity. He has made significant contributions to understanding FGF21 metabolic regulation, impacting blood glucose stability, blood pressure control, and anti-atherosclerosis therapies. His work also explores new targets for anti-myocardial infarction, heart failure, and vascular calcification drugs, driving innovation in metabolic and cardiovascular medicine. His research is widely recognized in international medical science.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Zhuofeng Lin’s academic journey began with a strong foundation in medical sciences, focusing on cardiovascular and metabolic diseases. His early research explored physiological mechanisms and metabolic interactions, leading him to specialize in cross-organ communication and metabolic regulation. His education and initial training laid the groundwork for his extensive contributions to cardiometabolic research.

🏢PROFESSIONAL ENDEAVORS:

Prof. Lin has held prestigious positions at Guangdong Medical University, where he currently serves as:

Dean of the Experimental Animal Center 🐁
Dean of the Innovational Center of Cardiometabolic Disease 🫀

His leadership in these institutions has driven significant advancements in experimental research methodologies and the development of innovative treatment strategies for metabolic disorders.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Prof. Lin’s research is dedicated to practical applications, with a strong emphasis on:

Cross-organ communication in cardiovascular and metabolic diseases
Pathogenesis of cardiometabolic disorders linked to metabolic hormones and obesity
Fibroblast Growth Factor 21 (FGF21) and its role in metabolic regulation

His studies have provided groundbreaking insights into FGF21’s ability to regulate:
✅ Blood glucose levels
✅ Blood pressure stability
✅ Anti-atherosclerosis mechanisms
✅ Anti-Metabolic Dysfunction-Associated Steatohepatitis (MASH) therapies

Additionally, his work focuses on discovering new therapeutic targets for:
⚕️ Anti-myocardial infarction drugs
⚕️ Anti-heart failure treatments
⚕️ Anti-vascular calcification solutions

🌍IMPACT AND INFLUENCE:

Prof. Lin’s research has had a profound impact on global medical science, particularly in the fields of:
🔹 Metabolic disease management
🔹 Cardiovascular treatment innovations
🔹 Therapeutic drug development

His studies have influenced clinical practices, contributing to better patient outcomes in cardiovascular and metabolic health. His pioneering work in hormonal regulation and metabolic stability has inspired numerous scientists and researchers worldwide.

📄ACADEMIC CITES AND RECOGNITION:

Prof. Lin’s research is widely recognized in high-impact medical journals, with numerous citations supporting his theories. His work on FGF21 metabolic regulation is frequently referenced in the fields of endocrinology, cardiology, and metabolic research. He has been a keynote speaker at international medical conferences, sharing his insights with the global scientific community.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With an unwavering commitment to scientific innovation, Prof. Lin continues to shape the future of medical research. His ongoing projects aim to:
🔬 Develop novel cardiometabolic therapies
🔬 Enhance cross-organ communication research
🔬 Introduce cutting-edge treatments for heart disease and metabolic disorders

His legacy will be defined by his transformative contributions to medicine, paving the way for future breakthroughs in cardiovascular and metabolic health.

💡CONCLUSION:

Prof. Dr. Zhuofeng Lin is a pioneering leader in cardiometabolic research, making groundbreaking contributions to understanding metabolic regulation and cardiovascular health. His work on FGF21 has revolutionized approaches to blood glucose stability, blood pressure control, and anti-atherosclerosis treatments . With a vision for therapeutic innovation, he continues to explore new drug targets for heart failure, myocardial infarction, and vascular calcification . His impact on medical science is profound, shaping the future of metabolic and cardiovascular treatments. His dedication ensures lasting advancements in healthcare and patient well-being.

TOP NOTABLE PUBLICATIONS

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Authors: Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, …
Journal: Cell Metabolism
Year: 2013

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Authors: Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, …
Journal: Circulation
Year: 2015

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

Authors: Z Lin, Z Wu, X Yin, Y Liu, X Yan, S Lin, J Xiao, X Wang, W Feng, X Li
Journal: PLoS One
Year: 2010

Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues

Authors: L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, …
Journal: Cell Reports
Year: 2019

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2

Authors: D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, …
Journal: Journal of Hepatology
Year: 2016

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Authors: Z Lin, Z Zhou, Y Liu, Q Gong, X Yan, J Xiao, X Wang, S Lin, W Feng, X Li
Journal: PLoS One
Year: 2011

FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice

Authors: X Pan, Y Shao, F Wu, Y Wang, R Xiong, J Zheng, H Tian, B Wang, …
Journal: Cell Metabolism
Year: 2018

Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice

Authors: Z Lin, F Wu, S Lin, X Pan, L Jin, T Lu, L Shi, Y Wang, A Xu, X Li
Journal: Journal of Hepatology
Year: 2014

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling‐dependent manner

Authors: Y Pan, B Wang, J Zheng, R Xiong, Z Fan, Y Ye, S Zhang, Q Li, F Gong, …
Journal: Journal of Cellular and Molecular Medicine
Year: 2019

Dynamic change of serum FGF21 levels in response to glucose challenge in human

Authors: Z Lin, Q Gong, C Wu, J Yu, T Lu, X Pan, S Lin, X Li
Journal: The Journal of Clinical Endocrinology & Metabolism
Year: 2012

Hua Zhaohui | Cardiovascular Researches | Best Researcher Award

Published on 25/02/202525/02/2025 by Cardiology and Cardiovascular Medicine

Dr. Hua Zhaohui | Cardiovascular Researches | Best Researcher Award

Dr. Hua Zhaohui, The First Affiliated Hospital of Zhengzhou University, China

Dr. Hua Zhaohui is an Associate Chief Physician, Associate Professor, and Master’s Supervisor at The First Affiliated Hospital of Zhengzhou University, China. As Director of Vascular Surgery (Group 5), he specializes in large vessel diseases, peripheral vascular disorders, and minimally invasive interventions. He has pioneered advanced vascular procedures in Henan Province and performs over 1,000 complex surgeries annually. A prolific researcher, he has led multiple funded projects and international collaborations, shaping the future of vascular surgery through innovation and excellence.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Hua Zhaohui embarked on his medical journey with a strong academic foundation. His dedication to vascular surgery began during his medical studies, where he demonstrated exceptional skills in diagnosing and treating complex vascular conditions. His early research and clinical training laid the groundwork for his later advancements in the field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Hua is currently an Associate Chief Physician, Associate Professor, and Master’s Supervisor at The First Affiliated Hospital of Zhengzhou University, China. He serves as the Director of Vascular Surgery (Group 5) and holds multiple leadership roles within the hospital, overseeing critical advancements in vascular treatment. Additionally, he is the Secretary of the Fourth Party Branch of the Department of Thyroid, Breast, and Vascular Surgery.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCHES:

Dr. Hua has made significant contributions to the field of vascular surgery through his pioneering techniques and research. His expertise includes:

Large Vessel Diseases: Aortic dissection, thoracoabdominal aortic aneurysm, Takayasu arteritis, and aortoiliac occlusive disease.
Peripheral Vascular Diseases: Thromboangiitis obliterans, arteriosclerosis obliterans, visceral artery aneurysm, subclavian artery stenosis, vertebral artery stenosis, and renal artery stenosis.
Minimally Invasive Treatments: Hybrid procedures, in vitro fenestration, and visceral artery reconstruction for aortic dissection/aneurysm.
Venous Disorders: Budd-Chiari syndrome, iliac vein compression syndrome, deep vein thrombosis, and portal hypertension.

🌍IMPACT AND INFLUENCE:

Dr. Hua has played a pivotal role in shaping the vascular surgery landscape in China and beyond. Notably:

He was the first in Henan Province to perform in vivo and in vitro fenestration for aortic dissection/aneurysm, carotid endarterectomy, carotid body tumor resection, and minimally invasive radiofrequency ablation for varicose veins.
He performs over 1,000 complex vascular surgeries annually, significantly impacting patient outcomes.
In March 2024, he was invited to the Almazov National Medical Center and the Second Hospital of Saint Petersburg in Russia to demonstrate advanced endovascular repair techniques.

📚ACADEMIC ACCOLADES AND CITATIONS:

Dr. Hua has contributed extensively to the academic community:

He serves as a Youth Editorial Board Member of the Chinese Journal of Vascular Surgery (Chinese and English Edition).
He has published multiple SCI and core Chinese journal articles, reflecting his ongoing research and dedication to the field.
He has led one project funded by the Henan Provincial Department of Education, two projects by the Henan Provincial Department of Science and Technology, and participated in four National Natural Science Foundation projects.

🏅LEADERSHIP AND PROFESSIONAL AFFILIATIONS:

Dr. Hua holds numerous prestigious positions in national and international vascular surgery organizations, including:

Chairman of the Youth Committee of the Vascular Surgery Branch of the Henan Medical Association.
Member of the Abdominal Aortic Aneurysm Group, Chinese Medical Doctor Association.
Deputy Chairman of the VTE Expert Committee, Henan Branch of the International Union of Angiology.
Vice Chairman and Secretary of the Neck Vascular Branch, Henan Stroke Society.
Standing Committee Member and Secretary of the Vascular Surgery Branch of the Henan Medical Association.

🔥LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Hua Zhaohui’s impact on vascular surgery continues to grow as he pioneers cutting-edge techniques and mentors the next generation of specialists. His relentless pursuit of excellence in research, innovation, and clinical practice ensures that his contributions will leave a lasting mark on global vascular surgery. His future initiatives aim to further advance minimally invasive treatments and expand international collaborations, reinforcing his status as a leader in vascular surgery.

🌍CONCLUSION:

Dr. Hua Zhaohui’s contributions to vascular surgery have transformed patient care and advanced medical science. His expertise in minimally invasive techniques, research excellence, and leadership roles place him at the forefront of the field. Through innovation, mentorship, and international collaboration, he continues to drive progress in vascular treatment. His legacy is defined by his commitment to improving surgical outcomes and training future generations of specialists. As he expands his influence globally, Dr. Hua remains a key figure in shaping the future of vascular surgery, ensuring better healthcare solutions for patients worldwide.

TOP NOTABLE PUBLICATIONS

Evaluating the Effectiveness of Immediate vs. Elective Thoracic Endovascular Aortic Repair for Blunt Thoracic Aortic Injury

Authors: Zhaohui Hua, Baoning Zhou, Wenhao Xue, Zhibin Zhou, Jintao Shan, Lei Xia, Yunpeng Luo, Yiming Chai, Zhen Li

Journal: Chinese Journal of Traumatology

Year: 2025

Classification and Management Strategy of Spontaneous Carotid Artery Dissection

Authors: Baoning Zhou, Zhaohui Hua, Chong Li, Zhouyang Jiao, Hui Cao, Peng Xu, Shirui Liu, Zhen Li

Journal: Journal of Vascular Surgery

Year: 2024

Pin-fang Kang | Cardiology | Best Researcher Award

Published on 24/02/202524/02/2025 by Cardiology and Cardiovascular Medicine

Mrs. Pin-fang Kang | Cardiology | Best Researcher Award

Mrs. Pin-fang Kang, Department of Cardiovascular Medicine of The First Affiliated Hospital of Bengbu Medical University, China

Mrs. Pin-fang Kang is a distinguished cardiovascular medicine specialist at the Department of Cardiovascular Medicine, The First Affiliated Hospital of Bengbu Medical University, China. Her research focuses on pulmonary hypertension, coronary artery disease, and cardiovascular therapies, contributing significantly to cardiology and medical innovation. She has co-authored multiple high-impact publications in prestigious journals, advancing the understanding of heart disease mechanisms and treatments. Her expertise in molecular cardiology and patient care has made her a key figure in cardiovascular research. Through her work, she continues to influence diagnostics, treatment strategies, and the future of cardiovascular medicine.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Mrs. Pin-fang Kang embarked on her academic journey with a strong passion for medical sciences, particularly in cardiovascular medicine. Her foundational education laid a solid groundwork for her future contributions in the field. She pursued rigorous training in medical studies, focusing on internal medicine and cardiovascular health, preparing her for a career dedicated to patient care and clinical research.

👩‍⚕️ PROFESSIONAL ENDEAVORS:

Currently serving in the Department of Cardiovascular Medicine at The First Affiliated Hospital of Bengbu Medical University, China, Mrs. Kang has established herself as a distinguished medical professional. Her expertise spans clinical cardiology, patient management, and innovative treatment approaches. She has actively engaged in treating various cardiovascular diseases, including hypertension, coronary artery disease, and heart failure.

🏥 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY:

Mrs. Kang has significantly contributed to advancing cardiovascular treatment methodologies. Her research primarily focuses on:

Innovative cardiovascular interventions
Prevention and management of heart diseases
The role of lifestyle and genetics in cardiovascular health
The impact of modern therapies on patient outcomes

Through her dedication to research and evidence-based medical practice, she has played a crucial role in improving cardiovascular health policies and patient treatment protocols.

🌍 IMPACT AND INFLUENCE:

Her work has influenced the Chinese medical community and contributed to global advancements in cardiovascular medicine. By integrating cutting-edge research with clinical applications, she has enhanced patient care and treatment methodologies. Her role as a mentor and educator at Bengbu Medical University has also inspired many young medical professionals.

📑 ACADEMIC CITES:

Mrs. Kang’s research has been cited in various scientific journals and medical conferences, establishing her as a key contributor to the field of cardiology. Her work has been referenced in:

Cardiovascular medical journals
International cardiology symposiums
Collaborative research studies with other medical institutions

🔬 LEGACY AND FUTURE CONTRIBUTIONS:

Mrs. Pin-fang Kang continues to pave the way for new advancements in cardiovascular medicine. Her future contributions are expected to revolutionize treatment strategies, enhance patient care, and mentor the next generation of cardiologists. With a commitment to medical excellence and innovation, she remains a pillar of the cardiovascular medical community.

⭐CONCLUSION:

Mrs. Pin-fang Kang stands as a dedicated expert in cardiovascular medicine, making remarkable contributions to research, patient care, and medical innovation. Her work on pulmonary hypertension, coronary artery disease, and advanced treatment methods has significantly impacted the field of cardiology. Through her cutting-edge research and clinical expertise, she continues to shape the future of cardiovascular health. As a respected figure in medical science, her dedication to improving diagnostics and therapies inspires the next generation of researchers and clinicians. Her legacy in cardiology remains invaluable for global healthcare advancements.

TOP NOTABLE PUBLICATIONS

Salidroside Ameliorates Hypoxic Pulmonary Hypertension by Regulating the Two-Pore Domain Potassium TASK-1 Channel

Authors: Zheng-Yu Sun, Guo-Qing Lu, Hong-Yan Sun, Wen-Di Jiang, Lei Wang, Yu-Hang Wang, Le-Qiang Liu, Hong-Ju Wang, Bi Tang, Qin Gao, Pin-Fang Kang

Journal: Phytomedicine

Year: 2024

Exploring the Diagnostic and Immune Infiltration Roles of Disulfidptosis Related Genes in Pulmonary Hypertension

Authors: Xin Tan, Ningning Zhang, Ge Zhang, Shuai Xu, Yiyao Zeng, Fenlan Bian, Bi Tang, Hongju Wang, Jili Fan, Xiaohong Bo, Yangjun Fu, Huimin Fan, Yafeng Zhou, Pinfang Kang

Journal: Respiratory Research

Year: 2024

Predicting Angiographic Coronary Artery Disease Using Machine Learning and High-Frequency QRS

Authors: Jiajia Zhang, Heng Zhang, Ting Wei, Bi Tang, Hongju Wang

Journal: BMC Medical Informatics and Decision Making

Year: 2024

Effect of NLRP3 Gene Knockdown on Pyroptosis and Ferroptosis in Diabetic Cardiomyopathy Injury

Authors: Jiahui Wang, Yuping Li, Lu Li, Ying Yu, Qin Gao

Journal: BMC Cardiovascular Disorders

Year: 2024

Activation of ALDH2 Alleviates Hypoxic Pulmonary Hypertension in Mice by Upregulating the SIRT1/PGC-1α Signaling Pathway

Authors: Lei Wang, Fenlan Bian, Feiyang Ma, Pin-Fang Kang, Shili Wu

Journal: Journal of Southern Medical University

Year: 2024

Quercetin Ameliorates Diabetic Kidney Injury in Rats by Inhibiting the HMGB1/RAGE/NF-κB Signaling Pathway

Authors: Y. Jiang, X. Li, J. Geng, Bi Tang, Pin-Fang Kang

Journal: Journal of Southern Medical University

Year: 2024

Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Published on 17/02/202517/02/2025 by Cardiology and Cardiovascular Medicine

Prof. Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Prof. Ming-Yow Hung, Shuang Ho Hospital, Taipei Medical University, Taiwan

Professor Ming-Yow Hung is a distinguished cardiologist and academic based at Shuang Ho Hospital, Taipei Medical University, in Taipei, Taiwan. He earned his Doctor of Medicine degree from Chang Gung University in 1996, followed by a Master of Science and a Ph.D. in Clinical Medical Sciences from the same institution in 2007 and 2017, respectively. Since 2022, he has been serving as a Professor in the Department of Internal Medicine at Taipei Medical University. His clinical expertise encompasses coronary interventions, peripheral interventions, and echocardiography. Professor Hung has received several accolades, including the 2022 TMU Academic Research Award and recognition in “Who’s Who in Medicine and Healthcare” in 2011 and 2012. His research interests focus on the mechanisms of inflammatory cytokines in coronary spasm and the anatomical and functional changes in the left ventricle of patients with coronary spasm.

Author Profile

Scopus Profile

Orcid Profile

🎓 Education:

Professor Ming-Yow Hung completed his medical education at the School of Medicine, College of Medicine, Chang Gung University, in Taoyuan, Taiwan, where he studied from September 1989 to June 1995. After earning his medical degree, he undertook an internship at Chang Gung Memorial Hospital in Taoyuan from June 1995 to June 1996. He later pursued postgraduate education, obtaining a Ph.D. in Clinical Medical Sciences from the Graduate Institute of Clinical Medical Sciences at Chang Gung University College of Medicine, where he studied from September 2007 to August 2017, further advancing his expertise in the field.

🏥Work Experience:

Professor Ming-Yow Hung began his military service as a Lieutenant General Physician in the Navy of Taiwan from August 1996 to May 1998. Afterward, he completed his residency in Internal Medicine at Chang Gung Memorial Hospital, Taoyuan, Taiwan, from July 1998 to June 2001, followed by a two-year cardiology fellowship from July 2001 to June 2003. He served as an attending cardiologist at the same hospital from July 2003 to May 2008. Since 2008, Professor Hung has been an attending cardiologist at Shuang Ho Hospital, Taipei Medical University. In academia, he progressed from Assistant Professor (2011-2017) to Associate Professor (2017-2022) and has been a Full Professor since February 2022.

🌟Professional Activities:

Professor Ming-Yow Hung has been actively involved in various professional roles throughout his career. From September 2004 to August 2005, he served on the Medical Record Management Committee at Chang Gung Memorial Hospital, Taoyuan. He was part of the Committee of Clinical Techniques and Medical Care for Clerkship Training from 2005 to 2006. He also served as the Director of the Intensive Care Unit at Shuang Ho Hospital from 2008 to 2009. Professor Hung was a faculty member at the 8th Annual Complex Cardiovascular Catheter Therapeutics Global Summit in 2012. He was the Director of Interventional Cardiology and Cardiac Cath Lab from 2014 to 2018. Additionally, he contributed to the Academic Educational Committee of the Taiwan Society of Echocardiography from 2008 to 2010.

🔬Research Interest:

Professor Ming-Yow Hung’s research interests focus on several key areas within cardiology. He specializes in interventional cardiology, particularly exploring innovative techniques and approaches in coronary and peripheral interventions. Additionally, his work emphasizes echocardiography, where he investigates advanced imaging techniques to enhance diagnostic accuracy and patient outcomes. Professor Hung is also deeply engaged in basic cardiovascular science, conducting research to better understand the underlying mechanisms of cardiovascular diseases. Through these areas of research, he aims to contribute to the advancement of both clinical practices and scientific knowledge in the field of cardiology.

🏆Honors and Awards:

Professor Ming-Yow Hung has received numerous honors and awards throughout his career. In 2001, he earned the Second Best Chart Record Award from the Department of Internal Medicine at Chang Gung Memorial Hospital. He was included in the 28th edition of Who’s Who in the World and the Who’s Who in Medicine and Healthcare (2011-2012). Notable accolades include invitations to speak at prestigious events like the Cardiology Grand Round at the University of California, San Diego, and the Complex Cardiovascular Catheter Therapeutics Global Summit. He also received multiple research awards from Taipei Medical University in 2014 and 2015, as well as recognition for his research achievements at Shuang Ho Hospital and various conferences in 2019 and 2022.

🌍Conclusion:

Professor Ming-Yow Hung is a highly accomplished cardiologist and academic, with expertise in interventional cardiology, echocardiography, and basic cardiovascular science. His extensive education, military service, and career at top medical institutions like Chang Gung Memorial Hospital and Taipei Medical University showcase his dedication to both clinical practice and research. Throughout his career, he has been recognized with numerous awards for his contributions to medicine and healthcare. His work continues to impact the field of cardiology, improving patient care and advancing scientific understanding.

Top Notable Publications

From Acute Carditis, Rheumatic Carditis, and Morphologic Cardiac Reactions to Allergic Angina, Allergic Myocardial Infarction and Kounis Syndrome: A Multidisciplinary and Multisystem Disease

Journal: Preprint

Year: 2025

Effects of statins in patients with coronary artery spasm: A nationwide population‐based study

Journal: Clinical and Translational Science

Cardio-Oncoimmunology: Cardiac Toxicity, Cardiovascular Hypersensitivity, and Kounis Syndrome

Journal: Life

Cardio-Oncology: Cardiac Toxicity, Cardiovascular Hypersensitivity, and Kounis Syndrome

Journal: Preprint

“When”, “Where”, and “How” of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review

Journal: Preprint

Outcomes of Atrioventricular Node Ablation and Pacing in Patients with Heart Failure and Atrial Fibrillation: From Cardiac Resynchronization Therapy to His Bundle Pacing

Journal: Journal of Cardiovascular Development and Disease

Year: 2023

Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review

Journal: International Journal of Molecular Sciences

Year: 2023

Relationship between Inflammation and Vasospastic Angina

Journal: Medicina

Year: 2023

The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review

Journal: Vaccines

Year: 2022

Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm

Journal: Oxidative Medicine and Cellular Longevity

Year: 2022

Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Published on 17/02/202517/02/2025 by Cardiology and Cardiovascular Medicine

Dr. Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Dr. Atsuko Nakayama, Sakakibara Heart Institute, Japan

Dr. Atsuko Nakayama, M.D., Ph.D., is a renowned cardiologist and expert in cardiovascular medicine and rehabilitation at the Sakakibara Memorial Hospital in Japan. She serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Dr. Nakayama is a pioneer in integrating AI and telemedicine into cardiac care and rehabilitation, with a focus on personalized treatment plans and wearable technologies. She holds leadership roles in several professional organizations and contributes to national policies on cardiovascular disease as a member of Japan’s Ministry of Health, Labour, and Welfare.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Atsuko Nakayama’s academic journey began with a strong foundation in medicine, culminating in a Doctorate from the prestigious University of Tokyo in March 2012. Her passion for cardiovascular medicine was evident from early on, and her academic excellence set the stage for a career that would merge clinical practice with cutting-edge research. Her early studies laid the groundwork for her future focus on medical device development, telemedicine, and rehabilitation in the cardiovascular field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Nakayama currently holds multiple leadership roles at the Sakakibara Memorial Hospital, where she serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Her leadership extends beyond her hospital, as she has been appointed as the representative of the Heart Disease Work-Life Balance Support Network in December 2024. Additionally, since June 2024, Dr. Nakayama has been a member of the Cardiovascular Disease Control Promotion Council under Japan’s Ministry of Health, Labour, and Welfare.

Her professional endeavors reflect a commitment to both the clinical and policy aspects of cardiovascular health. She has been at the forefront of integrating new technologies and rehabilitation approaches into routine care, improving patient outcomes through innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Dr. Nakayama’s research has focused on advancing the integration of technology in cardiovascular medicine, particularly through the use of artificial intelligence (AI) and telemedicine. She is recognized for her work in developing AI-driven diagnostic tools, wearable technologies, and remote cardiac rehabilitation programs. Her research also spans exercise physiology, aortic aneurysms, hypertrophic cardiomyopathy, and healthcare quality assessment.

Her pioneering work has enabled the development of AI-assisted patient monitoring systems and personalized treatment plans, revolutionizing cardiac rehabilitation. Dr. Nakayama has been instrumental in incorporating AI and big data analytics into cardiovascular care, allowing for predictive and preventive interventions in heart disease.

🌍IMPACT AND INFLUENCE:

Dr. Nakayama’s contributions extend well beyond the hospital and laboratory. Through her leadership in various professional organizations, including serving as the chair of the JCS-JJC committee of the Japanese Circulation Society since 2022, she has influenced the direction of cardiovascular research and practice in Japan. Her role in national policy-making, including her position on the Cardiovascular Disease Control Promotion Council, allows her to shape public health initiatives and promote AI-powered healthcare solutions on a national scale.

Her influence has been recognized by prestigious awards, including the “STI for SDGs” Award from the Japan Science and Technology Agency in 2024, recognizing her groundbreaking work in remotecardiac rehabilitation

📚ACADEMIC CITATIONS:

Dr. Nakayama’s research has been widely cited in the fields of telemedicine, AI in healthcare, and cardiovascular rehabilitation. Her work has paved the way for numerous studies exploring the use of technology to improve patient outcomes. As a fellow of both the Japanese Circulation Society and the American Heart Association, her research continues to have a significant impact on the scientific community.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Nakayama’s legacy is one of innovation, leadership, and compassionate care. Her contributions to AI-driven healthcare, particularly in the field of cardiology, have set new standards in patient care and rehabilitation. As she continues her work in AI-assisted diagnostics and rehabilitation, her future contributions promise to further revolutionize cardiovascular medicine and improve the lives of millions of patients.

Her ongoing efforts to shape policies, integrate cutting-edge technologies into clinical practice, and advocate for better healthcare systems ensure that Dr. Nakayama’s impact will be felt for years to come, leaving a lasting legacy in the world of medicine.

🌟CONCLUSION:

Dr. Atsuko Nakayama is a trailblazer in the field of cardiovascular medicine, combining clinical expertise with groundbreaking research in AI and telemedicine. Her leadership at Sakakibara Memorial Hospital, coupled with her contributions to national health policies, has made a lasting impact on cardiac care and rehabilitation in Japan. Through her innovative use of technology, she continues to improve patient outcomes and shape the future of healthcare. Dr. Nakayama’s dedication to advancing both medicine and healthcare systems ensures that her work will inspire generations of clinicians and researchers.

TOP NOTABLE PUBLICATIONS:

A national survey of career development according to gender and subspecialties among cardiologists in Japan
Authors: M. Shimbo, A. Nakayama, N. Fukue, T. Taniguchi, Y. Kobayashi
Journal: PLoS ONE
Year: 2025

Predicting Heart Rate at the Anaerobic Threshold Using a Machine Learning Model Based on a Large-Scale Population Dataset
Authors: A. Nakayama, T. Iwata, H. Sakuma, K. Kashino, H. Tomoike
Journal: Journal of Clinical Medicine
Year: 2025

Impact of Long-Term Exercise-Based Cardiac Rehabilitation in Patients With Chronic Heart Failure ― A Systematic Review and Meta-Analysis
Authors: S. Yamamoto, M. Okamura, Y. Akashi, S. Makita, M. Isobe
Journal: Circulation Journal
Year: 2024
Citations: 2

Sex Differences in Cardiovascular Disease-Related Hospitalization and Mortality in Japan ― Analysis of Health Records From a Nationwide Claim-Based Database, the Japanese Registry of All Cardiac and Vascular Disease (JROAD)
Authors: S. Noma, K. Kato, T. Otsuka, K. Maemura, Y.T. Tsukada
Journal: Circulation Journal
Year: 2024

Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Published on 17/02/202517/02/2025 by Cardiology and Cardiovascular Medicine

Prof. Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Prof. Litao Guo, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Prof. Litao Guo is a Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China. With over 18 years of experience in intensive care medicine, he specializes in cardiopulmonary resuscitation (CPR), ECMO therapy, and critical patient management. Prof. Guo is also an expert in intelligent simulation teaching for emergency skills training. His research includes advanced ECMO treatments and innovative CPR training methods using intelligent simulation platforms. He has published 16 research papers, contributing significantly to critical care medicine and improving patient outcomes in high-risk medical situations.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Litao Guo embarked on his academic journey in intensive care medicine, where he spent more than 18 years developing his expertise. From a resident to an associate chief physician, he gained valuable experience and hands-on knowledge in managing critically ill patients. Prof. Guo has also served as a master tutor, fostering the next generation of healthcare professionals, particularly in cardiopulmonary resuscitation (CPR) and ECMO treatment. This foundation in intensive care provided him with a deep understanding of patient management and critical interventions.

💼PROFESSIONAL ENDEAVORS:

Currently, Prof. Guo serves as the Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University in Xi’an, China. His daily responsibilities include overseeing the treatment and management of critically ill patients, particularly those requiring advanced life-saving procedures such as ECMO and CPR. He plays a pivotal role in shaping clinical practices, guiding patient care, and contributing to the advancement of intensive care medicine. His leadership is integral to the hospital’s focus on improving patient outcomes in high-stakes medical situations.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Prof. Guo is widely recognized for his research on intelligent simulation teaching and training methods, particularly in CPR. His work involves leveraging cutting-edge technology to enhance the teaching and practical skills of medical staff in emergency procedures. He has been instrumental in developing an intelligent simulation platform to train teams in effective CPR techniques, emphasizing team coordination, division of labor, and the standing position during resuscitation efforts. Additionally, his research delves into the management of ECMO therapy, focusing on treating complications such as massive airway bleeding with early clamping and advanced intervention measures.

🌍IMPACT AND INFLUENCE:

Prof. Guo’s research and clinical contributions have had a significant impact on improving outcomes for critically ill patients. His work on ECMO combined with advanced airway management has been especially groundbreaking, offering new insights and techniques to reduce mortality rates. His intelligent simulation teaching platform is transforming the way first responders and healthcare professionals are trained, ensuring they are equipped with the best skills to save lives. Prof. Guo’s publications, including 16 relevant research papers, have gained widespread recognition within the medical community.

📚ACADEMIC CITATIONS:

Prof. Guo has published 16 research papers, many of which focus on innovative approaches to CPR and ECMO. His scholarly work has contributed to the growing body of knowledge in intensive care medicine, particularly in areas that directly affect patient survival in critical care settings. These publications are frequently cited by other researchers, underscoring the importance of his work in advancing medical practice.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Guo is dedicated to further advancing intensive care medicine through both his clinical practice and research endeavors. His focus on innovative training techniques and treatment protocols, such as ECMO and CPR management, ensures that future healthcare providers will be well-equipped to manage complex and life-threatening situations. His legacy will be one of continuous improvement in the fields of sepsis, resuscitation, and critical care, with lasting effects on the healthcare system and patient care outcomes.

🌟CONCLUSION:

Prof. Litao Guo’s work in intensive care medicine, particularly in cardiopulmonary resuscitation (CPR) and ECMO therapy, has had a profound impact on improving patient care and outcomes in critical settings. His pioneering research on intelligent simulation platforms for emergency training is revolutionizing medical education, ensuring better preparedness among healthcare teams. With over 18 years of experience and 16 published papers, his contributions continue to shape the field. Prof. Guo’s commitment to advancing both clinical practice and medical education ensures that his legacy will inspire future generations of healthcare professionals.

TOP NOTABLE PUBLICATIONS

Exploration of cardiopulmonary resuscitation teamwork training for maternal cardiac arrest using the SimMan intelligent simulation platform: A simulation teaching study

Authors: Zhang, Ruirui; Liu, Yu; Zhang, Mingming; Bai, Hongliang; Guo, Litao

Journal: Health Science Reports

Year: 2024

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Authors: Vaara, Suvi T.; Neto, Ary Serpa; Bellomo, Rinaldo; Yang, Yang; Padayachee, Laven

Journal: Critical Care Explorations

Year: 2024

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Published on 17/02/202517/02/2025 by Cardiology and Cardiovascular Medicine

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen, Wenzhou Medical university, China

Dr. Lingyan Chen is an Associate Researcher at Wenzhou Medical University, China, specializing in mitochondrial quality control and disease pathogenesis. She holds a Ph.D. from Wenzhou Medical University (2019-2022) and completed a postdoctoral fellowship at Guangzhou Medical University (2019-2024). Her research focuses on gene knockout models, tumor studies, and cardiovascular pharmacology. She has received multiple awards, including honors from the Circulation Journal Awards (Japan) and the Zhejiang Society of Biochemistry. With extensive experience in molecular biology techniques, Dr. Chen continues to advance biomedical research, aiming to develop novel therapeutic strategies for metabolic and cardiovascular diseases.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Lingyan Chen embarked on her academic journey at Changsha Medical University, earning a B.Sc. degree (2006-2009). She then pursued a M.Sc. at The University of South China (USC) (2015-2018), where she focused on pathogenesis and prevention of atherosclerosis, supported by prestigious research grants. She completed her Ph.D. at Wenzhou Medical University (WMU) (2019-2022), concentrating on mitochondrial quality control and its implications for related diseases.

🏥PROFESSIONAL ENDEAVORS:

🔹 Guangzhou Medical University (Postdoctoral Researcher) (2019-2024) – Advanced research in mitochondrial pathogenesis and disease modeling.
🔹 Guangzhou Medical School (Assistant Professor) (2018) – Engaged in pharmacology research on cardiovascular diseases.
🔹 Guangzhou Medical University (Research Assistant) (2018) – Coordinated multi-institutional research projects and managed key laboratory operations.
🔹 The Second People’s Hospital of Changde (Pediatric Nurse) (2009-2015) – Provided clinical care for newborns and critically ill children, mentoring trainee nurses.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Chen’s research spans multiple domains in biomedical sciences, including:
✅ Mitochondrial Quality Control & Disease Mechanisms – Investigated gene knockout/knockin mice models, heterogeneous tumors, and disease modeling for liver cancer and diabetes.
✅ Cardiovascular Pharmacology – Conducted Western Blotting, qPCR, immunofluorescence, and genetic experiments on macrophage behavior.
✅ Atherosclerosis & Hypertriglyceridemia – Studied clinical patient data, serum sample analysis, and statistical evaluations to uncover disease mechanisms.

🌍IMPACT AND INFLUENCE:

Dr. Chen has significantly influenced mitochondrial pathogenesis and cardiovascular research, contributing valuable insights into gene expression, disease prevention, and targeted treatments. Her research findings have aided in therapeutic advancements, particularly in cardiovascular disorders and metabolic diseases.

📚ACADEMIC CITES & LEGACY:

Dr. Chen’s research has been published in top-tier scientific journals, earning citations in the fields of biochemistry, molecular biology, and cardiovascular medicine. Her work serves as a foundation for future studies in mitochondrial dysfunction and therapeutic innovations.

🚀FUTURE CONTRIBUTIONS & VISION:

As an Associate Researcher at Wenzhou Medical University (2025-Present), Dr. Chen continues her groundbreaking research in mitochondrial medicine and disease pathogenesis. She aims to:
🔹 Develop novel therapeutic strategies for cardiovascular and metabolic disorders.
🔹 Expand research on genetic and molecular mechanisms underlying disease progression.
🔹 Mentor the next generation of biomedical researchers and medical professionals.

🏆AWARDS AND HONORS:

🔹 2020 – Second Prize in the 16th Graduate Academic Competition, Wenzhou Medical University
🔹 2020 – Second Prize in the “Xinzhi” Youth Forum, Zhejiang Society of Biochemistry and Molecular Biology
🔹 2018 – Second Prize for Excellent Experimental Research Paper, Circulation Journal Awards (Japan)
🔹 2018 – Outstanding Communist of the University of South China
🔹 2017 – 3rd Prize, Young Investigator Oral Presentation, 14th National Conference on Atherosclerotic Diseases & China-Canada Symposium
🔹 2017 – Excellence Award, Young Investigator Oral Presentation, Cross-Strait Cardiovascular Science Symposium
🔹 2017 – 1st Scholarship, University of South China
🔹 2016 – 2nd Scholarship, University of South China
🔹 2015 – 2nd Scholarship, University of South China

🌟CONCLUSION:

Dr. Lingyan Chen’s dedication to biomedical research, particularly in mitochondrial quality control and cardiovascular pharmacology, has significantly contributed to understanding disease mechanisms and potential treatments. Her extensive experience in molecular biology, combined with numerous accolades and publications, underscores her impact in the scientific community. As she continues her research at Wenzhou Medical University, Dr. Chen remains committed to advancing medical science, mentoring future researchers, and developing innovative therapeutic strategies. Her work holds great promise for improving treatments for metabolic and cardiovascular diseases, making her a valuable figure in the field of biomedical research.

TOP NOTABLE PUBLICATIONS

Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

Authors: Chen, Lingyan; Chen, Dejian; Pan, Yiming; Zhang, Dawei; Xia, Xiaodan

Journal: Cell Death and Disease

Year: 2024

Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells

Authors: Chen, Lingyan; Chen, Dejian; Li, Jiwei; Lu, Xiaoang; Lu, Bin

Journal: Cell Death and Disease

Year: 2022

MicroRNA-377 inhibits atherosclerosis by regulating triglyceride metabolism through the DNA methyltransferase 1 in apolipoprotein E-knockout mice

Authors: Chen, Lingyan (First Author); Xia, Xiaodan; Zhao, Zhiwei; Gong, Dan; Ma, Xuefeng; Yu, Xuhui; Zhang, Qi; Wang, Shengqi; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Yin, Wende; Tang, ChaoKun

Journal: Circulation Journal

Year: 2018

Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells

Authors: Xia, Xiaodan; Yu, Xuhui; Chen, Lingyan (Co-first Author); Xie, Shuo; Feng, Yan; Yang, Rui; Zhao, Zhiwei; Li, Hui; Wang, Gang; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids

Year: 2021

Heart shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway

Authors: Zhao, Zhiwei; Zhang, Min; Chen, Lingyan (Co-first Author); Gong, Dan; Xia, Xiaodan; Yu, Xuhui; Wang, Shengqi; Ou, Xue; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta

Year: 2018

Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages

Authors: Li, ChaoHui; Gong, Dan; Chen, Lingyan (Co-first Author); Zhang, Min; Xia, Xiaodan; Cheng, Hongping; Huang, Chen; Zhao, Zhiwei; Zheng, Xianliang; Tang, XueEr; Tang, ChaoKun

Journal: European Journal of Pharmacology

Year: 2017

IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells

Authors: Tang, XueEr; Li, Hui; Chen, Lingyan (Co-first Author); Xia, Xiaodan; Zhao, Zhiwei; Zheng, Xianliang; Zhao, GuoJun; Tang, ChaoKun

Journal: Cytokine

Year: 2019

Xuhui Lin | Recent Advancements | Best Researcher Award

Published on 12/02/202512/02/2025 by Cardiology and Cardiovascular Medicine

Mr. Xuhui Lin | Recent Advancements| Best Researcher Award

Mr. Xuhui Lin, The Alan Turing Institute, United Kingdom

Mr. Xuhui Lin is a researcher in sustainable urban systems , specializing in transportation resilience, graph theory, and AI-driven infrastructure analysis . He is currently pursuing an MPhil/PhD at University College London (UCL) , focusing on enhancing urban road network resilience under flooding . Lin has worked with leading institutions, including The Alan Turing Institute, UCL, University of Georgia, and UC Berkeley . His research spans digital twins, smart cities, and AI applications in urban planning . With multiple high-impact publications and top academic distinctions , he is dedicated to shaping sustainable, data-driven urban solutions.

Author Profile

Scopus Profile

Google Scholar Profile

🎓 Education:

Mr. Xuhui Lin is currently pursuing an MPhil/PhD in Sustainable Construction at University College London (UCL) , focusing on enhancing urban transportation resilience through graph dynamic systems under flooding (2023–Present). He previously earned an MSc in Digital Innovation in Built Asset Management from UCL (2022–2023) , ranking in the top 1% with distinction. Lin holds a Bachelor of Design in Architecture from the University of Sydney (2015–2018), graduating 1st Class Honors, top 1%. He also attended UCL Summer School (2017) and briefly studied Commerce at The University of Sydney (2014).

💼 Work Experience:

Mr. Xuhui Lin is a Researcher under the Enrichment Scheme at The Alan Turing Institute (2024–2025) , applying graph theory and synchronization models to analyze urban transportation resilience. Simultaneously, he works as a Research Assistant at DAFNI , developing digital twins to assess congestion risks during floods. He previously contributed to Visual Large Language Models at the University of Georgia and applied graph network algorithms to biological data at Southern Medical University . As an Algorithm Engineer at UC Berkeley , he refined 3D AI-powered robot interfaces. Lin also worked at UrbanX Lab & Alibaba (2018–2022), developing digital twins for urban regeneration. His past roles include urban planning at Tsinghua University, flood resilience studies at UCL, and point-of-interest analysis for commercial optimization. He has a strong interdisciplinary background, integrating AI, transportation systems, and urban planning into resilient, data-driven solutions.

🚀Research Interests:

Mr. Xuhui Lin’s research focuses on urban resilience, transportation networks, and digital innovation in the built environment . His work integrates graph theory, synchronization dynamics, and field theory to enhance urban transportation resilience under extreme events like flooding . He is passionate about data-driven urban planning, employing AI, machine learning, and large-scale simulations to optimize infrastructure performance. Lin explores multimodal urban systems, developing digital twins to assess congestion risks and predict transportation disruptions. His interdisciplinary approach extends to biomedical engineering , where he applies network analysis to biological data for drug development. Additionally, he investigates human-AI interactions, refining 3D interfaces for robotics and smart cities. With expertise in spatial cognition, computational urban design, and digital asset management, Lin aims to bridge the gap between technology and sustainable city planning, fostering smarter, more adaptive urban environments for the future.

🔬 Research Experience:

Mr. Xuhui Lin has an extensive research background spanning urban resilience, digital innovation, AI-driven infrastructure analysis, and biomedical engineering . At The Alan Turing Institute, he applies graph theory to assess transportation network complexity and enhance urban mobility under disruptions . As a Research Assistant at DAFNI, he developed digital twins to evaluate congestion risks during floods . His work at University of Georgia focused on Visual Large Language Models (VLLMs) for urban spatial analysis, while at Southern Medical University, he explored biological information networks for drug discovery . Lin also contributed to 3D user interfaces for AI-powered robotics at UC Berkeley and conducted transport resilience studies at UCL. His expertise in machine learning, graph neural networks, and digital asset management enables cutting-edge research at the intersection of smart cities, AI, and infrastructure resilience, driving sustainable urban transformation.

🏆 Awards and Honors:

Mr. Xuhui Lin has received numerous prestigious awards and honors for his outstanding contributions to urban resilience, AI-driven infrastructure analysis, and digital innovation . He graduated Top 1% with Distinction in both his MSc at UCL and Bachelor of Design in Architecture at the University of Sydney . His research excellence earned him a position as a Researcher under the Enrichment Scheme at The Alan Turing Institute . He has also received multiple academic scholarships and grants for his work in graph theory, transportation resilience, and digital twins . Lin’s contributions to high-impact journals such as Reliability Engineering & System Safety and IEEE Transactions on Intelligent Transportation Systems further highlight his scholarly impact . His multidisciplinary expertise, spanning AI, urban planning, and biomedical research, has solidified his reputation as a leading researcher in smart city innovation and infrastructure resilience.

🔍 Conclusion:

Mr. Xuhui Lin’s research embodies a cutting-edge fusion of urban resilience, AI, and network dynamics . His work advances transportation sustainability, digital twins, and smart city innovations , contributing to real-world solutions for flood-prone urban networks . With extensive research collaborations, high-impact publications, and algorithmic advancements , Lin continues to push the boundaries of data-driven urban infrastructure. His commitment to sustainable and intelligent urban planning ensures his work remains impactful and forward-thinking . As cities evolve, his expertise will be crucial in designing resilient, adaptive, and efficient urban systems for the future.

Top Notable Publications

Title: Automated building information modeling compliance check through a large language model combined with deep learning and ontology
Authors: N Chen, X Lin, H Jiang, Y An
Journal: Buildings
Year: 2024

Title: Sandpile-simulation-based graph data model for MVD generative design of shield tunnel lining using information entropy
Authors: Y An, X Lin, H Li, Y Wang
Journal: Advanced Engineering Informatics
Year: 2023

Title: Assessing dynamic congestion risks of flood-disrupted transportation network systems through time-variant topological analysis and traffic demand dynamics
Authors: X Lin, Q Lu, L Chen, I Brilakis
Journal: Advanced Engineering Informatics
Year: 2024

Title: Rethinking the city resilience: COM-B model-based analysis of healthcare accessing behaviour changes affected by COVID-19
Authors: J Yan, Z Fang, L Chen, J Tang, Q Lu, X Lin
Journal: Journal of Housing and the Built Environment
Year: 2024

Title: RESHAPE: Rapid forming and simulation system using unmanned aerial vehicles for architectural representation
Authors: X Lin, R Muslimin
Journal: CAADRIA Proceedings
Year: 2019

Title: Development and Validation of a Novel Model to Discriminate Idiosyncratic Drug‐Induced Liver Injury and Autoimmune Hepatitis
Authors: Y Wang, X Lin, Y Sun, J Liu, J Li, Q Tian, F Guo, X Hu, L Wang, P Li, …
Journal: Liver International
Year: 2025

Title: Benchmarking best practice of digital built asset management
Authors: X Lin, P Liu, J Yan, X Chen
Journal: Digital Built Asset Management
Year: 2024

Title: Enhancing Urban Flood Response: Traffic Flow Prediction with Field Theory-Inspired Physics-Informed Graph Neural Network
Authors: X Lin, Q Lu, T Broyd, T Cheng, X Zhang, T Erfani, TH Tran
Journal: –
Year: 2024

Title: Developing a context-based bounded centrality approach of street patterns in flooding: a case study of London
Authors: X Lin, Q Lu, N Gunn, S Sølvsten
Journal: UCL
Year: 2023

Yingqiang Du | Myocardial Infarction | Best Researcher Award

Published on 12/02/202512/02/2025 by Cardiology and Cardiovascular Medicine

Dr. Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du, Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Municipal Hospital; Gusu School, Nanjing Medical University, China

Dr. Yingqiang Du is a renowned cardiology researcher at The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, China. His research focuses on myocardial infarction and ischemic heart disease, exploring inflammation, fibrosis, metabolic remodeling, and novel therapeutic strategies. As the first or corresponding author of multiple high-impact publications, he has significantly contributed to cardiovascular medicine. His work bridges basic and clinical research, influencing treatment advancements and patient care. With ongoing projects funded by prestigious grants, Dr. Du continues to drive innovation in cardiology, shaping the future of cardiovascular health research.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Yingqiang Du began his academic journey with a strong foundation in medical sciences, focusing on cardiology and cardiovascular research. His early education provided him with a deep understanding of human physiology, pathology, and the complexities of ischemic heart disease. With a keen interest in myocardial infarction and its underlying mechanisms, he pursued specialized training and research, laying the groundwork for his future contributions to the field.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Du is affiliated with The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University. As a researcher and academic professional, he has taken on significant responsibilities in both clinical and experimental cardiology. His work bridges the gap between theoretical research and practical applications, ensuring that scientific findings translate into improved patient care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Du’s research primarily centers on myocardial infarction and ischemic heart disease. His studies delve into various aspects, including:

The role of inflammation and fibrosis in cardiovascular conditions.
The impact of environmental factors, such as micro(nano)plastics, on heart disease.
Novel therapeutic approaches involving bioactive compounds like resveratrol and muscone.
The involvement of metabolic remodeling and inflammasome activation in aging cells. His extensive work provides crucial insights into the prevention, diagnosis, and treatment of cardiac disorders.

🌟 IMPACT AND INFLUENCE:

Dr. Du’s research has had a profound impact on the field of cardiology. His studies have contributed to a better understanding of the molecular mechanisms of myocardial infarction and fibrosis, paving the way for new treatment modalities. His findings have influenced clinical practices and have been referenced in various medical and scientific discussions worldwide.

📖 ACADEMIC CITES:

As an established researcher, Dr. Du has authored multiple high-impact publications in reputed journals, including:

Journal of Hazardous Materials
Clinical and Translational Medicine
Experimental and Therapeutic Medicine
Bioengineered
American Journal of Translational Research These publications, where he serves as either the first or corresponding author, reflect his credibility and expertise in the field. His work has been widely cited by peers, demonstrating its relevance and significance.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Du’s contributions to cardiology are paving the way for future breakthroughs in cardiovascular medicine. His research findings are not only enhancing current medical knowledge but also inspiring upcoming researchers to explore novel therapeutic strategies. Moving forward, his work is expected to contribute significantly to:

The development of innovative drug treatments for myocardial infarction.
The formulation of preventive measures against ischemic heart disease.
The exploration of new molecular pathways for better cardiovascular health. His ongoing commitment to research excellence ensures that his legacy will continue to shape the future of cardiology.

🌍CONCLUSION:

Dr. Yingqiang Du is a distinguished researcher whose groundbreaking contributions to cardiology have significantly advanced the understanding of myocardial infarction and ischemic heart disease. His extensive studies on inflammation, fibrosis, and metabolic remodeling have influenced both clinical practices and future research directions. With multiple high-impact publications and ongoing projects, his work continues to shape modern cardiovascular medicine.

TOP NOTABLE PUBLICATION

Title: Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome

Authors: X., Gu, Xin, Z., Zhang, Zhixuan, L., Zhao, Lin, … X., Wang, Xiaoyan, Y., Du, Yingqiang

Journal: Journal of Hazardous Materials

Year: 2025